BAMCO Inc’s Roivant Sciences ROIV Stock Holding History

BAMCO Inc’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.42M	Hold	125,000	–	–	0.01%	264
2026 Q1	$3.46M	Hold	125,000	–	–	0.01%	261
2025 Q4	$2.71M	Buy	125,000 +20,000	+19%	+$395K	0.01%	275
2025 Q3	$1.59M	Buy	+105,000	New	+$1.3M	﹤0.01%	290

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BAMCO Inc's ROIV Position: Q2 2026 in Review

BAMCO Inc held its Roivant Sciences (ROIV) position steady in Q2 2026 at 125,000 shares worth $4.42M. The position accounts for 0.01% of the portfolio, ranked #264.

BAMCO Inc first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

BAMCO Inc held 125,000 shares of Roivant Sciences worth $4.42M as of Q2 2026.
BAMCO Inc left its Roivant Sciences share count unchanged in Q2 2026.
Roivant Sciences made up 0.01% of BAMCO Inc's portfolio in Q2 2026, its #264 holding.
BAMCO Inc first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.